Verici Dx plc (LON:VRCI – Get Free Report) shares fell 17.2% during mid-day trading on Friday . The company traded as low as GBX 0.35 and last traded at GBX 0.35. 4,546,681 shares traded hands during trading, an increase of 184% from the average session volume of 1,599,974 shares. The stock had previously closed at GBX 0.43.
Verici Dx Trading Down 17.2%
The firm has a market capitalization of £5.33 million, a P/E ratio of -0.12 and a beta of 1.30. The company has a quick ratio of 8.49, a current ratio of 0.91 and a debt-to-equity ratio of 11.36. The business has a 50-day moving average price of GBX 0.46 and a 200-day moving average price of GBX 0.61.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
